Already lacking the Covid-19 pandemic? Properly, worry not. The German-EU “VACCELERATE” programme is already looking out for the subsequent “pathogen with pandemic potential,” as authors affiliated with the programme put it in a brand new paper titled “Predicting the subsequent pandemic.”
The paper is dedicated to a survey of the VACCELERATE consortium’s personal members on the pathogen most certainly to supply the “subsequent pandemic” – or the subsequent “potential pandemic generator,” because the authors additionally put it. The responses concerned a rating of the varied candidates and have been tallied utilizing a factors system, very like the Eurovision tune contest.
And the winner is…
Influenza! The flu was named by practically 80% of respondents and garnered practically one-third of the factors. A hitherto unknown “Illness X” completed second, and the Coronaviruses, SARS-CoV-2 and SAR-Cov-1, completed third and fourth respectively. The complete outcomes are reproduced under.
In response to the challenge description on the funding web page, the programme’s unique goal, in line with the target of EUVAP, was to create an EU-wide community of medical trial websites and a registry of prepared trial contributors, in an effort to fast-track particularly Covid-19 vaccine candidates. “The continuing COVID-19 pandemic creates an unprecedented burden worldwide” the outline reads,
Vaccine-induced immunity is the one promising answer. There may be continued want for part 2 & 3 vaccine trials to succeed in long-term, large-scale immunity of your complete European inhabitants. VACCELERATE would be the pan-European spine accelerating part 2 & 3 COVID-19 vaccine trials.
With COVID-19 vaccines having already been rolled out in file time shortly earlier than its launch, by the point EUVAP had morphed into VACCELERATE in 2021, this unique goal was, in fact, largely out of date. Therefore, the programme’s pivot towards the subsequent “pathogen with pandemic potential” is hardly shocking.
